A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer

NCT00381095 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

152

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Bone Neoplasms
Pain, Intractable
Cancer

Interventions

DRUG: Pregabalin
DRUG: Placebo

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.